MEMBRANELIPIDTHERAPY

Membrane lipid composition as new antitumor therapeutic target: sphingomyelin synthase (SGMS) at the basis of Minerval® mechanism of action and design of new Minerval®-related drugs.

assignment_turned_inproject01 Sep 2014(Started)-02 May 2017(Ended)Closed

Funder: European CommissionProject code: 627441 Call for proposal: FP7-PEOPLE-2013-IEF

Funded under: FP7 | SP3 | PEOPLE

Detailed project information (CORDIS)

MEMBRANELIPIDTHERAPY

- Summary
- DMPs

Partners

UIB

Data Management Plans

Start a new DMP in Argos

Found an issue? Give us feedback

Select content type to embed

All Research products

arrow_drop_down

<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=corda_______::0351ffd7df39c4c2e361eaf003752ece&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

MEMBRANELIPIDTHERAPY

MEMBRANELIPIDTHERAPY

Loading